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obesity status (yes/no). Patients with moderate pain at baseline
had a 1.6 fold greater odds (95% CI 1.0-2.6) of a 20% placebo
response and 1.7 fold (95% CI 1.0-2.9) than those with either
low (≤ 30) or high (≥70) levels of baseline pain.
A 20% reduction in pain was associated with higher baseline
pain (38.7 ± 21.6 vs. 31.8 ± 20.9, p = 0.008), and a trend
(p = 0.08) toward greater joint space width (3.02 ± 0.60 vs.
2.90 ± 0.57). No between-group differences were evident in
use of pain medication or glucosamine, though 20% placebo
responders were less likely to use analgesics 75% or more of
the time during the trial (OR = 0.43; 95% CI 0.26-0.73). No
differences were observed between placebo 50% responders
and non-responders in sociodemographic or joint characteristics.
Patients with a 50% decrease in pain were less likely to report
use of pain medications at baseline (OR = 0.41; 95% CI 0.22-
0.76), chronically (OR = 0.57; 95% CI 0.33 - 0.97) or during the
trial (OR = 0.37; 95% CI = 0.22-0.65). 50% responders were
also less likely to have OA in 1+ other sites (OR = 0.30; 95%
CI = 0.11-0.79) with a trend toward a greater odds of using
glucosamine (OR = 1.6; 95% CI 0.92 - 2.8).
Conclusions: As in other large OA trials, nearly half of per-
sons receiving placebo had clinically detectable and 29% had
clinically meaningful improvements in pain. Placebo responders
were more likely to report moderate pain at baseline and less
likely to use pain medications. Overall, there do not appear
to be sociodemographic or disease-related characteristics that
can reliably predict placebo response. However, OA trials often
selectively target individuals with moderate pain and less medi-
cation use - factors that may increase the prevalence of placebo
responders.
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Purpose: It is unclear whether involvement of certain joint areas
have a particular impact on the patients pain and function.
The objective of the present study was to investigate the asso-
ciation between clinically assessed ﬁnger joint involvement and
outcome measures.
Methods:One hundred and ninety female HOA patients between
50 and 70 years of age with a mean (SD) age of 61.6 (5.6) years
completed a comprehensive clinical examination including as-
sessment of joint status and fulﬁllment of several questionnaires,
among them AUSCAN, AIMS2 and VAS scale for pain. Grip
strength was examined as a performance based assessment.
Associations were examined by Pearson correlation coefﬁcients.
Levels of health status were compared across areas of joint
involvement by Student T-test.
Results: The mean (SD) number of joints showing bony enlarge-
ment was 0.39 (0.66) for CMC joints, 2.86 (2.91) for PIP joints
and 4.47 (2.56) for DIP joints.The number of involved PIP joints
was signiﬁcantly correlated to AUSCAN pain (r=0.21, p=0.005)
and stiffness (r=0.21,p=0.006), and the number of DIP joints
showed a signiﬁcant correlation to grip strength bilaterally (r=-
0.19, p=0.01 right hand and -1.55, p=0.04 left hand).Health status
levels in patients with and without presence of joint involvement
are shown in table. Only a small number of differences were
statistically signiﬁcant (Table).
Conclusions: Worse health status was associated with an in-
creased number of joints involved, but the ﬁndings did not sup-
port the assumption that involvement of speciﬁc joint areas could
have any major impact on outcome measures.
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Purpose: Although many people suffer from pain and disability
due to osteoarthritis (OA) in the lower extremities, knowledge
about progression of OA and how to assess progression of OA
is limited. The purpose of the present study is to investigate
currently available outcome measures, that assess clinical as
well as structural and social aspects of OA, to evaluate their
responsiveness in a series of patients with OA in the lower
extremities over a two year follow-up.
Methods: Participants of the GARP study (Genetics, ARthro-
sis and Progression) - a 2-year follow-up study in patients with
familial OA at multiple sites- with symptomatic knee or hip OA
were included in the present study. Knee or hip OA were de-
ﬁned following the American College of Rheumatology criteria
for knee and hip OA, requiring both symptoms on most days of
the preceding month in addition to radiographic abnormalities.
Standardized knee and hip radiographs were made at baseline
and follow-up. Medial and lateral tibiofemoral joints and hips
were scored by 2 readers in consensus for change in joint space
narrowing (JSN) using the OARSI atlas. Readers scored the
radiographs paired and blind for sequence. Radiographic total
scores ranged from 0-18. Smallest detectable difference over 2
years was one point. Pain intensity in knees and hips upon pas-
sive movement (a modiﬁcation of the Doyle index) was graded
during physical examination on a 4-point scale for intensity (max-
imal total score 0-16). Self-reported pain and physical function
for the lower extremities, including both knees and hips, were
evaluated by Western Ontario and McMasters Universities os-
teoarthritis index (WOMAC) in its visual analogue scale format;
scores ranged from 0-100. Social functioning was assessed with
the social functioning score (range 0-100; higher score indicate
better social functioning) of the RAND 36-item Health Survey.
Standardized response means (SRMs) were calculated to evalu-
ate responsiveness.
Results: Of the 127 eligible patients for the present study 115
(91%) patients (mean age 60 years, 80% female) completed
the 2 year follow-up. Symptomatic hip OA and knee OA were
present in 76 and 53 patients respectively and 14 patients had
a combination of both. 23% of the patients had an increase
of at least one point in JSN total scores. An increase in pain
intensity total scores at physical examination was present in
46% of patients, whereas a decrease was observed in 19% of
the patients. Statistically signiﬁcant deterioration in JSN (mean
change 0.3 (95% CI 0.2-0.4)) and pain intensity total score (0.9
(0.5-1.3) were seen in the whole patient population. SRMs were
0.43 and 0.41, respectively. WOMAC pain and function scores
showed small non-signiﬁcant deterioration. SRMs were 0.15 and
0.18 respectively. No change was seen in social functioning
scores (SRM 0.01).
Conclusions: The current study suggests that instruments mea-
suring structural abnormalities and clinical symptoms during
physical examination are more responsive to change over 2
years in patients with OA in the lower extremities than self-
reported measurements of pain, disability and social functioning
in OA. Whether these ﬁndings reﬂect the course of the OA pro-
cess in the patients or are associated on the type and quality
of the instruments has to be investigated. Further validation and
development of instruments to evaluate OA progression is war-
ranted to improve the measurement of disease outcome in OA
of the lower extremities.
